GleamWall
中文EN

BLGO BIOLARGO, INC.

Chemicals & Allied Products · OTC · SEC CIK 880242 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-62.3%
TTM net income YoY-7.8%
TTM EPS YoY—
Revenue 3-yr CAGR-25.8%
Net income 3-yr CAGR—

Margins

Gross margin43.7%
Operating margin-355.4%
Net margin-260.6%
FCF margin—
EBITDA margin-349.9%

Returns

ROE-1,608.5%
ROA-129.8%
ROIC (approx.)—
Asset turnover0.50x

Leverage & solvency

Liabilities / assets165.9%
Debt / equity—
Current ratio0.60x
Interest coverage-14.79x

Cash quality & payout

Operating cash flow / net income0.92x
Accruals ratio-10.2%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY2025*2025-12-31FY2024*2024-12-31
Income statement
Revenue$7.76M$17.78M
Cost of revenue$4.36M$9.93M
Gross profit$3.41M$7.85M
R&D expense$2.59M$2.88M
SG&A expense$11.77M$9.30M
Operating income-$14.86M-$4.33M
Interest expense$540,000$71,000
Pretax income-$15.19M-$4.35M
Income tax—$0
Net income-$11.78M-$2.40M
EBITDA-$14.71M-$4.18M
EPS (basic)-0.04-0.01
EPS (diluted)——
Banking
Net interest income-$340,000-$33,000
Balance sheet
Cash & equivalents$3.88M$3.55M
Receivables$615,000$3.17M
Inventory$310,000$330,000
Current assets$5.11M$7.14M
PP&E, net$1.64M$1.74M
Total assets$8.31M$10.51M
Current liabilities$5.06M$2.65M
Short-term debt—$66,000
Long-term debt$2.08M$1.08M
Total debt$2.08M$1.15M
Total liabilities$6.79M$4.46M
Shareholders' equity$4.04M$8.85M
Net debt-$1.80M-$2.40M
Cash flow statement
Operating cash flow-$8.30M-$3.21M
Investing cash flow$435,000-$1.32M
Financing cash flow$8.22M$4.44M
Depreciation & amortization$145,000$155,000
Stock-based compensation$2.96M$2.06M

Free plan shows the latest 2 periods; Pro shows all 16 🔒

· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.